Quantcast

Latest Lexicon Pharmaceuticals Stories

2014-04-14 12:32:44

Conference Call and Webcast at 8:30 a.m. Eastern Time THE WOODLANDS, Texas, April 14, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today positive, top-line results in a Phase 2 clinical trial of LX4211 in type 1 diabetes, which achieved the primary endpoint of reducing mealtime insulin use as well as several secondary endpoints, including improved glycemic control. LX4211 is an oral, first-in-class, dual inhibitor of sodium glucose transporters 1 and 2...

2014-04-03 08:28:59

THE WOODLANDS, Texas, April 3, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Needham Healthcare Conference on Tuesday, April 8, 2014 at 9:20 AM EDT in New York City. Lexicon management will provide an overview of Lexicon's clinical development programs and milestones. A webcast of the presentation will be available through Lexicon's website at www.lexpharma.com. An archived version of the presentation...

2014-02-28 08:24:53

Conference Call and Webcast at 11:00 a.m. Eastern Time THE WOODLANDS, Texas, Feb. 28, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2013. "We made important progress in our late-stage drug development programs in 2013, completing multiple studies of LX4211...

2014-02-25 23:22:28

The market for mice model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and other services (surgical and line rescue) - http://www.marketsandmarkets.com/Market-Reports/mice-model-market-1308.html. (PRWEB) February 25, 2014 This report studies “Mice Model Market - By Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding,...

2014-02-20 08:29:05

Conference Call and Webcast to Follow THE WOODLANDS, Texas, Feb. 20, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, will release its fourth quarter and year end 2013 financial results on Friday, February 28, 2014 before the financial markets open. Lexicon management will hold a conference call and webcast to discuss clinical development progress and financial results for...

2014-02-10 04:21:31

DUBLIN, February 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/wlcf6t/mice_model_market) has announced the addition of the "Mice Model Market - by Type, Technology, Disease, Service & Care Products - Forecasts to 2018" [http://www.researchandmarkets.com/research/wlcf6t/mice_model_market ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Over the years, the use of mice models...

2014-02-06 23:04:50

Mice Model Market report categorizes the global mice model market into the following segments and sub-segments - By Type, By Technology, By Disease, By Service & Geography. (PRWEB) February 06, 2014 This report studies “Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018”. The...

2014-02-03 08:26:45

THE WOODLANDS, Texas, Feb. 3, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the BIO CEO & Investor Conference on Monday, February 10, at 10:30 AM EST in New York City. Lexicon management will provide an overview of Lexicon's clinical development programs and milestones. A webcast of the presentation will be available through Lexicon´s website at www.lexpharma.com. An archived version of the...

2014-01-29 16:29:03

DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/q8l6jf/lexicons) has announced the addition of the "Lexicon's telotristat - A new approach to carcinoid syndrome" [http://www.researchandmarkets.com/research/q8l6jf/lexicons ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Lexicon is developing telotristat as therapy for carcinoid syndrome, an orphan' disease that occurs...

2014-01-20 12:23:08

LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019 Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019 Summary GBI Research has released its latest report for the pharmaceuticals industry, "Type 2 Diabetes...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related